top of page

Pharmaceutical Products

Displayed on this page are pharmaceutical products in development by Innovative Potential.

Chaperone Molecule.png

All Known EAC Molecules

Do you have a highly sensitive or short-lived compound  that you are having difficulty bringing to market?

​​

Well now you can thanks to the wonders of EAC!

​

Chaperone your molecule for  electrochemical activation with Innovative Potential to protect and extend the real-world functionality, and profitability, of your next molecule!

​​

EAC also applies to all known bioactivatable molecules!

Penecillin Chaperone_edited.jpg

All EAC Antibiotics

Ever consider chaperoning a champion like Penicillin to stop  environmentally-acquired antibiotic resistant strains from developing?

​

You should.

I did, and now I'm telling you.

This one is kind've important.

​

The EAC-antibiotics are capable of being brought to market with a CGP-only removable chaperone group.

 

This CGP-specific leaving group can preserve an antibiotic's potency against antibiotic resistant strain development.

​

The CGP is patented under Innovative Potential.

Electramide

Electramide is a cyclophoshamide formulation in a CGP-friendly electrolyte solution.

​

Electramide is a specialty cyclophosphamide formulation for CGP and EAC drug development work including electrolysis assessments, in vitro bioassay screening, and in vivo testing.

​

Electramide is not a regulated medical product, and is for research purposes only.

Electramide
™ is not for human or veterinary use.

Electrophen

Electrophen is an acteaminophen  formulation in a CGP-friendly electrolyte solution.

​

Electrophen is a specialty acetaminophen formulation for CGP and EAC drug development work including electrolysis assessments, in vitro bioassay screening, and in vivo testing.

​

Electrophen is not a regulated medical product, and is for research purposes only.

Electrophen
™ is not for human or veterinary use.

ProLact

ProLact is a live-culture dairy product that contains a genetically modified organism (GMO) for lactose intolerant people.

​

ProLact™ is a GMO-probiotic that inhabits the gut microbiome for approximatley one week post consumption, and has been modified to constituitively express and secrete human lactase enzymes into the lumen of the small intestine. 

​

ProLact digests lactose using human lactase enzymes for people who are lactose intolerant.

​

ProLact is currently in development and not a regulated medical or food product, and is strictly for research purposes only, for now.

Not for human or veterinary use.

Innovative Potential - Plain Logo Plus.png

© Innovative Potential Inc., L.L.C., 2016-2025.
Ab Initio: 1997; A Quo: 2009; Creatum Est: 2016; A Lex: 2017; A Patentatus: 2021.

bottom of page